SBI in $1 billion funding for Sun Pharma’s US deal
Published on: June 9, 2026, 3:05 p.m. | Source: The Economic Times
State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co. This move marks a significant step for government-run banks in financing corporate takeovers. SBI will join other global lenders in this substantial deal. The funding underscores the growing ambition of Indian companies to expand globally.
